| Hepatitis e N Kamar, R Bendall, F Legrand-Abravanel, NS Xia, S Ijaz, J Izopet, ... The Lancet 379 (9835), 2477-2488, 2012 | 1176 | 2012 |
| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 893 | 2022 |
| Hepatitis E: an emerging infection in developed countries HR Dalton, R Bendall, S Ijaz, M Banks The Lancet infectious diseases 8 (11), 698-709, 2008 | 870 | 2008 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 712 | 2021 |
| Persistent carriage of hepatitis E virus in patients with HIV infection HR Dalton, RP Bendall, FE Keane, RS Tedder, S Ijaz New England Journal of Medicine 361 (10), 1025-1027, 2009 | 641 | 2009 |
| Hepatitis E virus in blood components: a prevalence and transmission study in southeast England PE Hewitt, S Ijaz, SR Brailsford, R Brett, S Dicks, B Haywood, ... The Lancet 384 (9956), 1766-1773, 2014 | 619 | 2014 |
| Transfusion‐transmitted hepatitis E in a ‘nonhyperendemic’country E Boxall, A Herborn, G Kochethu, G Pratt, D Adams, S Ijaz, CG Teo Transfusion medicine 16 (2), 79-83, 2006 | 389 | 2006 |
| Hepatitis E virus and neurologic disorders N Kamar, RP Bendall, JM Peron, P Cintas, L Prudhomme, JM Mansuy, ... Emerging infectious diseases 17 (2), 173, 2011 | 378 | 2011 |
| A comparison of two commercially available anti‐HEV IgG kits and a re‐evaluation of anti‐HEV IgG seroprevalence data in developed countries R Bendall, V Ellis, S Ijaz, R Ali, H Dalton Journal of medical virology 82 (5), 799-805, 2010 | 354 | 2010 |
| Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and … HR Dalton, W Stableforth, P Thurairajah, S Hazeldine, R Remnarace, ... European journal of gastroenterology & hepatology 20 (8), 784-790, 2008 | 342 | 2008 |
| Hepatitis E outbreak on cruise ship B Said, S Ijaz, G Kafatos, L Booth, HL Thomas, A Walsh, M Ramsay, ... Emerging infectious diseases 15 (11), 1738, 2009 | 337 | 2009 |
| Non–travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics S Ijaz, E Arnold, M Banks, RP Bendall, ME Cramp, R Cunningham, ... The Journal of infectious diseases 192 (7), 1166-1172, 2005 | 290 | 2005 |
| Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre … CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ... The Lancet Microbe 2 (8), e354-e365, 2021 | 277 | 2021 |
| The role of hepatitis E virus testing in drug‐induced liver injury HR Dalton, HJ Fellows, W Stableforth, M Joseph, PH Thurairajah, ... Alimentary pharmacology & therapeutics 26 (10), 1429-1435, 2007 | 272 | 2007 |
| Hepatitis E virus: Assessment of the epidemiological situation in humans in Europe, 2014/15 C Adlhoch, A Avellon, SA Baylis, AR Ciccaglione, E Couturier, ... Journal of Clinical Virology 82, 9-16, 2016 | 216 | 2016 |
| Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study RK Gupta, EM Harrison, A Ho, AB Docherty, SR Knight, M van Smeden, ... The Lancet Respiratory Medicine 9 (4), 349-359, 2021 | 207 | 2021 |
| Autochthonous hepatitis E in southwest England HR Dalton, PH Thurairajah, HJ Fellows, HS Hussaini, J Mitchell, ... Journal of viral hepatitis 14 (5), 304-309, 2007 | 198 | 2007 |
| Antibody-based assay discriminates Zika virus infection from other flaviviruses A Balmaseda, K Stettler, R Medialdea-Carrera, D Collado, X Jin, ... Proceedings of the National Academy of Sciences 114 (31), 8384-8389, 2017 | 195 | 2017 |
| Hepatitis E virus infection in Europe: surveillance and descriptive epidemiology of confirmed cases, 2005 to 2015 EJ Aspinall, E Couturier, M Faber, B Said, S Ijaz, L Tavoschi, J Takkinen, ... Eurosurveillance 22 (26), 30561, 2017 | 173 | 2017 |
| SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus MI Andersson, CV Arancibia-Carcamo, K Auckland, JK Baillie, E Barnes, ... Wellcome open research 5, 2020 | 171 | 2020 |
